Vytorin Labeling Shows Superiority To Lipitor, Zocor
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck/Schering-Plough Vytorin sales reps will use clinical data in FDA-approved labeling demonstrating superiority in reducing LDL cholesterol to both Merck's Zocor and Pfizer's Lipitor